Clinical Trials Insight: 700028351
Phase of Trial: Phase I
Latest Information Update: 14 Apr 2008
At a glance
- Drugs Gallium nitrate (Primary)
- Indications Malignant hypercalcaemia
- Focus Adverse reactions; Pharmacokinetics; Registrational
- Sponsors Genta
- 14 Apr 2008 Results will be presented at ASCO 2008.
- 14 Apr 2008 Status change from in progress to completed, as reported in a Genta media release.
- 15 Nov 2007 Interim results will be presented at the annual meeting of the American Society of Hematology in December 2007.